Baldwin Brothers LLC Nuvectis Pharma, Inc. Transaction History

Baldwin Brothers LLC

  • $1.38 Billion
  • Q2 2025

A detailed history of Baldwin Brothers LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 350,461 shares of NVCT stock, worth $2.14 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
350,461
Previous 358,461 2.23%
Holding current value
$2.14 Million
Previous $3.75 Million 30.19%
% of portfolio
0.19%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 24, 2025
SELL
$7.47 - $10.96 $59,760 - $87,680
-8,000 Reduced 2.23%
350,461 $2.62 Million
Q1 2025

Apr 14, 2025
BUY
$5.37 - $10.46 $13,425 - $26,150
2,500 Added 0.7%
358,461 $3.75 Million
Q4 2024

Jan 22, 2025
BUY
$4.52 - $10.98 $821,876 - $2 Million
181,831 Added 104.42%
355,961 $1.93 Million
Q3 2024

Oct 15, 2024
BUY
$6.16 - $7.23 $33,880 - $39,765
5,500 Added 3.26%
174,130 $1.1 Million
Q2 2024

Jul 12, 2024
BUY
$5.98 - $8.25 $86,710 - $119,625
14,500 Added 9.41%
168,630 $1.07 Million
Q1 2024

Apr 12, 2024
BUY
$6.69 - $11.0 $80,882 - $132,990
12,090 Added 8.51%
154,130 $1.26 Million
Q4 2023

Jan 08, 2024
BUY
$7.85 - $11.78 $201,431 - $302,274
25,660 Added 22.05%
142,040 $1.18 Million
Q3 2023

Oct 10, 2023
BUY
$12.89 - $16.29 $339,251 - $428,736
26,319 Added 29.22%
116,380 $1.5 Million
Q2 2023

Jul 14, 2023
SELL
$12.62 - $18.4 $678,186 - $988,797
-53,739 Reduced 37.37%
90,061 $1.44 Million
Q1 2023

Apr 21, 2023
BUY
$7.32 - $14.37 $76,860 - $150,885
10,500 Added 7.88%
143,800 $1.89 Million
Q4 2022

Jan 27, 2023
BUY
$6.7 - $7.74 $2,010 - $2,322
300 Added 0.23%
133,300 $0
Q3 2022

Oct 14, 2022
BUY
$7.09 - $13.0 $85,080 - $156,000
12,000 Added 9.92%
133,000 $943,000
Q2 2022

Jul 18, 2022
BUY
$7.02 - $20.44 $849,420 - $2.47 Million
121,000 New
121,000 $1.36 Million

Others Institutions Holding NVCT

# of Institutions
50
Shares Held
3.21M
Call Options Held
44.5K
Put Options Held
50.1K
View Full List

About Nuvectis Pharma, Inc.

NVCT Quotes by TradingView
  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $89.5M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email